Study [Reference] Patient number Stage of cancer Rate of T3-T4 disease Dose (Gy) Hormonal therapy Median f/u (year) bNED DSS OS Late GI toxicity Late GU toxicity Shipley [16] 202…
Fig. 5.1 Image registration measuring geometric variation between treatment planning and actual positioning prior to the start of treatment (blended images of planning CT and kV-CBCT images are shown) Ideally,…
Fig. 21.1 Axial computed tomography images showing isodose distributions for conventional (top left) and intensity-modulated radiation therapy (top right) plans for a patient with a gynecologic malignancy. The graph (bottom)…
Fig. 14.1 A forward-planned intensity-modulated radiation therapy (IMRT) plan (left) vs. a conventional wedge plan (right) Fig. 14.2 A 107 % isodose cloud (blue) visible on a digitally reconstructed radiograph…
Fig. 10.1 A 63-year-old former smoker presented with a 3.5 cm painful mass of the left lateral border of the oral tongue (photograph). Biopsy of this mass showed moderately differentiated,…
TNM staging system for prostate cancer Primary tumor(T) TX Primary tumor cannot be assessed T0 No evidence of primary tumor T1 Clinically inapparent tumor neither palpable nor visible by imaging…
Fig. 3.1 Relative surviving fractions of EMT6 and SCCVII cells after 8 Gy given without a break or in 5 fractions at various intervals. Cell survival after continuous 8-Gy irradiation…
Author/study PTV Dose/fraction Fractions BED CHT MST Floyd et al. [21] GTV 5.0 Gy 10 75 Gy No 7 m n = 18 Sultanem et al. [22] GTV 3.0 Gy 20 78…
Number F/U Age Tonsil BT CS IV T4 N2b Dose PTV1 Dose PTV2 Dose PTV3 CRT (%) SIB OS LCR PFS Sher 163 36 M 56.1 50 45 75…
Reference and year of publication Study design Number of patients IMRT dose/fraction size, Gy Chemotherapy % with resected disease Median progression-free survival time, months Median overall survival time, months Neoadjuvant…
